Randomized, Open-label, Superiority Trial of the Effectiveness of Gatifloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Enteric Fever.
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2016
At a glance
- Drugs Ceftriaxone (Primary) ; Gatifloxacin (Primary)
- Indications Typhoid
- Focus Therapeutic Use
- 02 Oct 2016 Status changed from active, no longer recruiting to completed.
- 21 Jun 2013 Planned End Date changed from 1 Mar 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 10 Apr 2012 Additional lead trial centre (Civil Hospital, Nepal) and investigator (Gajurel D) added as reported by ClinicalTrials.gov.